BRIDGEBIO PHARMA LLC reported 1 transaction at BRIDGEBIO ONCOLOGY THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 10/16/2025ACC: 0001193125-25-241634
10% Owner
Since Aug 2025
+784.72K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
784.72K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+784.72K
Price / share
—
Trade value
—
% of position
5.7%
10/10/2025
13.81M→14.59M
Total
Net shares
+784.72K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/10/2025 | J · J | +784.72K | — | — | 5.7% | 13.81M | 14.59M |
| Total | +784.72K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported